These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15770483)

  • 1. Soluble CD21 in sera and synovial fluid of arthritic patients.
    Grottenthaler T; von Kempis J; Goldacker S; Illges H
    Rheumatol Int; 2006 Jan; 26(3):240-3. PubMed ID: 15770483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis.
    Masilamani M; von Kempis J; Illges H
    Rheumatology (Oxford); 2004 Feb; 43(2):186-90. PubMed ID: 12867574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of soluble CD21 from human plasma by affinity chromatography and density gradient centrifugation.
    Masilamani M; Apell HJ; Illges H
    J Immunol Methods; 2002 Dec; 270(1):11-8. PubMed ID: 12379334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD21 (sCD21) forms biologically active complexes with CD23: sCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells.
    Frémeaux-Bacchi V; Fischer E; Lecoanet-Henchoz S; Mani JC; Bonnefoy JY; Kazatchkine MD
    Int Immunol; 1998 Oct; 10(10):1459-66. PubMed ID: 9796912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of soluble complement receptor 2/CD21 in systemic lupus erythomatosus and Sjogren's syndrome but not juvenile arthritis.
    Masilamani M; Nowack R; Witte T; Schlesier M; Warnatz K; Glocker MO; Peter HH; Illges H
    Scand J Immunol; 2004 Dec; 60(6):625-30. PubMed ID: 15584974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid syndrome patients display reduced titers of soluble CD21 in their sera irrespective of circulating anti-beta2-glycoprotein-I autoantibodies.
    Singh A; Blank M; Shoenfeld Y; Illges H
    Rheumatol Int; 2008 May; 28(7):661-5. PubMed ID: 18172655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic reduction of soluble complement receptor II/CD21 during pregnancy to levels reminiscent of autoimmune disease.
    Masilamani M; Rajasekaran N; Singh A; Low HZ; Albus K; Anders S; Behne F; Eiermann P; König K; Mindnich C; Ribarska T; Illges H
    Rheumatol Int; 2008 Sep; 28(11):1137-41. PubMed ID: 18500464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased levels of sCD21 and sCD23 in blood of patients with systemic-juvenile arthritis, polyarticular-juvenile arthritis, and pauciarticular-juvenile arthritis.
    Singh A; Vastert SJ; Prakken BJ; Illges H
    Rheumatol Int; 2012 Jun; 32(6):1581-7. PubMed ID: 21328056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The levels of soluble forms of CD21 and CD83 in multiple sclerosis.
    Karampoor S; Zahednasab H; Etemadifar M; Keyvani H
    J Neuroimmunol; 2018 Jul; 320():11-14. PubMed ID: 29759135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectodomain shedding and generation of two carboxy-terminal fragments of human complement receptor 2/CD21.
    Hoefer MM; Illges H
    Mol Immunol; 2009 Aug; 46(13):2630-9. PubMed ID: 19524299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble CD21 induces activation and differentiation of human monocytes through binding to membrane CD23.
    Frémeaux-Bacchi V; Aubry JP; Bonnefoy JY; Kazatchkine MD; Kolb JP; Fischer EM
    Eur J Immunol; 1998 Dec; 28(12):4268-74. PubMed ID: 9862364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of soluble CD21 in patients with systemic sclerosis.
    Tomita M; Kadono T; Yazawa N; Kawashima T; Tamaki Z; Ashida R; Ohmatsu H; Asano Y; Sugaya M; Kubo M; Ihn H; Tamaki K; Sato S
    Rheumatol Int; 2012 Feb; 32(2):317-21. PubMed ID: 21052675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell activation leads to shedding of complement receptor type II (CR2/CD21).
    Masilamani M; Kassahn D; Mikkat S; Glocker MO; Illges H
    Eur J Immunol; 2003 Sep; 33(9):2391-7. PubMed ID: 12938215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Epstein-Barr virus nuclear antigen-2 (EBNA2) induces CD21/CR2 on B and T cell lines and shedding of soluble CD21.
    Larcher C; Kempkes B; Kremmer E; Prodinger WM; Pawlita M; Bornkamm GW; Dierich MP
    Eur J Immunol; 1995 Jun; 25(6):1713-9. PubMed ID: 7614999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Origin and properties of soluble CD21 (CR2) in human blood.
    Ling NR; Hardie DL; Johnson GD; MacLennan IC
    Clin Exp Immunol; 1998 Sep; 113(3):360-6. PubMed ID: 9737663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23.
    Frémeaux-Bacchi V; Bernard I; Maillet F; Mani JC; Fontaine M; Bonnefoy JY; Kazatchkine MD; Fischer E
    Eur J Immunol; 1996 Jul; 26(7):1497-503. PubMed ID: 8766552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of sCD21 in Human Blood Using ELISA is Influenced by Ethylenediaminetetraacetic Acid (EDTA) Containing Blood Collection Tubes.
    Linke K; Illges H
    Clin Lab; 2015; 61(11):1803-8. PubMed ID: 26732009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced CD21 expression and shedding in chronic lymphatic leukemia: a possible pathomechanism in disease progression.
    Low HZ; Hilbrans D; Schmidt-Wolf IG; Illges H
    Int J Hematol; 2012 Sep; 96(3):350-6. PubMed ID: 22899340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the Epstein-Barr virus receptor CD21 in multiple sclerosis.
    Toepfner N; Cepok S; Grummel V; Hemmer B
    J Neuroimmunol; 2012 Jan; 242(1-2):47-51. PubMed ID: 22137275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of Salmonella and Yersinia in the pathogenesis of spondyloarthropathies and rheumatoid arthritis. II. Antibodies to Salmonella and Yersinia in sera and synovial fluids].
    Rastawicki W; Jagielski M; Gierczyński R; Garwolińska H; Kwiatkowska B; Filipowicz-Sosnowska A
    Med Dosw Mikrobiol; 2005; 57(2):143-51. PubMed ID: 16134386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.